I have trained in Specialist Ophthalmology in the Wessex region since 1999. I have also completed sub-specialty training in Medical retinal diseases and Retinal Gene therapy from Oxford in 2012. In July 2011, I was awarded a nationally competitive HEFCE Clinical Senior Lectureship and was appointed at University of Southampton. Before this, a Southampton NHS research training fellowship in 2003 allowed me to undertake and successfully complete a PhD into the genetics and immunology of age-related macular degeneration (AMD). My preliminary research has made significant progress in unravelling the molecular basis of this disease by linking specific Human Leukocyte Antigen (HLA) and killer-cell immunoglobulin-like receptor (KIR) genotypes with AMD. My research was the first to demonstrate a pharmacogenetic correlation within AMD for treatments. I continue to integrate research clinically to improve AMD treatment outcomes for patients. My research has also been accepted for presentations at prestigious meetings including the House of Lords Parliamentary scientific meeting, the Royal College of Ophthalmologists (UK) and the Association of Research in Vision and Ophthalmology (ARVO) annual meetings (USA). My standing in Ophthalmology has also been recognised by my role as a reviewer for EYE journal since 2003.
I have had extensive training in all aspects of general ophthalmic surgery and phacoemulsification cataract surgery. I have successfully performed over 1500 such procedures to date, of which many have been complex cataracts. I have also gained expertise in retinal ophthalmic procedures such as retinal laser treatments (PASCAL/Argon/Photodynamic therapy/ORAYA, etc) and intravitreal injection procedures (Lucentis/Avastin/Ozurdex, etc). I also enjoy teaching surgical skills to ophthalmic trainees and undergraduates. I continue to publish clinically relevant research and have mentored many junior ophthalmologists in the art of writing abstracts for ophthalmology meetings, helping identify research and audit projects for them and in their preparation and submission of case reports for publications.
My long-term academic interest in clinical ophthalmology is focused on developing new clinical treatments (both gene therapy and stem cell based therapies) for age related macular degeneration (AMD), the commonest cause of blindness in the Western world.